Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00222664
Status:
COMPLETED
Last Update Posted:
2005-09-22
First Post:
2005-09-13
Brief Title:
Qidong Hepatitis B Intervention Study
Sponsor:
University of Oxford
Organization:
University of Oxford
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2005-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
During 1983-1990 in the Jiangsu province of China 80000 infants were randomised by area of birth between control standard Hepatitis B vaccination at 0 1 and 6 months of age and standard vaccination plus a booster dose at about 2 to 3 years of age The aim is to prevent establishment of chronic HBV infection in early childhood hence to prevent the morbidity of chronic hepatitis B in young adolescents and the incidencemortality several decades later from liver cancer and other HBV related chronic liver diseases Long-term follow-up through central registries will determine the impact of vaccination on liver cancer incidence and mortality
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None